SignatureFD’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
SignatureFD's STOK Position: Q3 2026 in Review
SignatureFD held its Stoke Therapeutics (STOK) position steady in Q3 2026 at 83 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #3174.
SignatureFD first reported a position in STOK in Q3 2021 and has held it in 12 quarters since. The position peaked at $12K in Q1 2022. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- SignatureFD held 83 shares of Stoke Therapeutics worth $2.16K as of Q3 2026.
- SignatureFD left its Stoke Therapeutics share count unchanged in Q3 2026.
- Stoke Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3174 holding.
- SignatureFD first reported a position in Stoke Therapeutics in Q3 2021 and has held it in 12 quarters since.
- SignatureFD's Stoke Therapeutics position peaked at $12K in Q1 2022.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.